OPC-167832

OPC-167832 · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for OPC-167832, covering 2023-11-18 to 2026-08-12. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB [Phase 2]

See pricing